English
简体中文
Total: £ 56.28
Published Date: 2025-07-14 | Pages: 98 | Tables: 99 | Medical Care
The global market for Clinical Trial Imaging Service was valued at US$ 1579 million in the year 2024 and is projected to reach a revised size of US$ 2501 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Medical imaging now plays a vital role in clinical trials. Reputation and credibility in Clinical Trials are paramount. Confidence is key which demands the highest quality specialists with unbiased and professional imaging support.Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.
The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.
In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.
Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.
For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.
In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.
With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.
The driving factors of the clinical trial imaging market mainly include the following:
Technological progress: innovation drives core growth
High-precision and multimodal imaging technology
Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.
Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.
Artificial Intelligence and Automation
AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.
Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.
Portable and Real-time Imaging
Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.
Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.
Policy support: Create a favorable development environment
Improvement of regulatory framework
FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.
International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.
Funding and Incentives
Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.
Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.
Growth in medical demand: changes in population and disease structure
Aging and chronic disease burden
High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.
Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).
New drug development and clinical trial expansion
Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.
Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.
The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging Service.
The Clinical Trial Imaging Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Trial Imaging Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Keosys
Konica Minolta
Segment by Type
In-house Imaging Service
Central Imaging Service
Segment by Application
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Research Institutes
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Imaging Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Imaging Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 In-house Imaging Service
1.2.3 Central Imaging Service
1.3 Market by Application
1.3.1 Global Clinical Trial Imaging Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnology Companies
1.3.4 Medical Device Manufacturers
1.3.5 Research Institutes
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Imaging Service Market Perspective (2020-2031)
2.2 Global Clinical Trial Imaging Service Growth Trends by Region
2.2.1 Global Clinical Trial Imaging Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Trial Imaging Service Historic Market Size by Region (2020-2025)
2.2.3 Clinical Trial Imaging Service Forecasted Market Size by Region (2026-2031)
2.3 Clinical Trial Imaging Service Market Dynamics
2.3.1 Clinical Trial Imaging Service Industry Trends
2.3.2 Clinical Trial Imaging Service Market Drivers
2.3.3 Clinical Trial Imaging Service Market Challenges
2.3.4 Clinical Trial Imaging Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Imaging Service Players by Revenue
3.1.1 Global Top Clinical Trial Imaging Service Players by Revenue (2020-2025)
3.1.2 Global Clinical Trial Imaging Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Clinical Trial Imaging Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Trial Imaging Service Revenue
3.4 Global Clinical Trial Imaging Service Market Concentration Ratio
3.4.1 Global Clinical Trial Imaging Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Imaging Service Revenue in 2024
3.5 Global Key Players of Clinical Trial Imaging Service Head office and Area Served
3.6 Global Key Players of Clinical Trial Imaging Service, Product and Application
3.7 Global Key Players of Clinical Trial Imaging Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Imaging Service Breakdown Data by Type
4.1 Global Clinical Trial Imaging Service Historic Market Size by Type (2020-2025)
4.2 Global Clinical Trial Imaging Service Forecasted Market Size by Type (2026-2031)
5 Clinical Trial Imaging Service Breakdown Data by Application
5.1 Global Clinical Trial Imaging Service Historic Market Size by Application (2020-2025)
5.2 Global Clinical Trial Imaging Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Trial Imaging Service Market Size (2020-2031)
6.2 North America Clinical Trial Imaging Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Trial Imaging Service Market Size by Country (2020-2025)
6.4 North America Clinical Trial Imaging Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Imaging Service Market Size (2020-2031)
7.2 Europe Clinical Trial Imaging Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Trial Imaging Service Market Size by Country (2020-2025)
7.4 Europe Clinical Trial Imaging Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Imaging Service Market Size (2020-2031)
8.2 Asia-Pacific Clinical Trial Imaging Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Clinical Trial Imaging Service Market Size (2020-2031)
9.2 Latin America Clinical Trial Imaging Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Trial Imaging Service Market Size by Country (2020-2025)
9.4 Latin America Clinical Trial Imaging Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Imaging Service Market Size (2020-2031)
10.2 Middle East & Africa Clinical Trial Imaging Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Details
11.1.2 ICON Business Overview
11.1.3 ICON Clinical Trial Imaging Service Introduction
11.1.4 ICON Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.1.5 ICON Recent Development
11.2 ERT
11.2.1 ERT Company Details
11.2.2 ERT Business Overview
11.2.3 ERT Clinical Trial Imaging Service Introduction
11.2.4 ERT Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.2.5 ERT Recent Development
11.3 McLaren
11.3.1 McLaren Company Details
11.3.2 McLaren Business Overview
11.3.3 McLaren Clinical Trial Imaging Service Introduction
11.3.4 McLaren Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.3.5 McLaren Recent Development
11.4 Bioclinica
11.4.1 Bioclinica Company Details
11.4.2 Bioclinica Business Overview
11.4.3 Bioclinica Clinical Trial Imaging Service Introduction
11.4.4 Bioclinica Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.4.5 Bioclinica Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Clinical Trial Imaging Service Introduction
11.5.4 Parexel Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.5.5 Parexel Recent Development
11.6 BioTelemetry
11.6.1 BioTelemetry Company Details
11.6.2 BioTelemetry Business Overview
11.6.3 BioTelemetry Clinical Trial Imaging Service Introduction
11.6.4 BioTelemetry Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.6.5 BioTelemetry Recent Development
11.7 ProScan Imaging
11.7.1 ProScan Imaging Company Details
11.7.2 ProScan Imaging Business Overview
11.7.3 ProScan Imaging Clinical Trial Imaging Service Introduction
11.7.4 ProScan Imaging Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.7.5 ProScan Imaging Recent Development
11.8 Imaging Endpoints
11.8.1 Imaging Endpoints Company Details
11.8.2 Imaging Endpoints Business Overview
11.8.3 Imaging Endpoints Clinical Trial Imaging Service Introduction
11.8.4 Imaging Endpoints Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.8.5 Imaging Endpoints Recent Development
11.9 Radiant Sage
11.9.1 Radiant Sage Company Details
11.9.2 Radiant Sage Business Overview
11.9.3 Radiant Sage Clinical Trial Imaging Service Introduction
11.9.4 Radiant Sage Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.9.5 Radiant Sage Recent Development
11.10 Micron, Inc.
11.10.1 Micron, Inc. Company Details
11.10.2 Micron, Inc. Business Overview
11.10.3 Micron, Inc. Clinical Trial Imaging Service Introduction
11.10.4 Micron, Inc. Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.10.5 Micron, Inc. Recent Development
11.11 Intrinsic Imaging
11.11.1 Intrinsic Imaging Company Details
11.11.2 Intrinsic Imaging Business Overview
11.11.3 Intrinsic Imaging Clinical Trial Imaging Service Introduction
11.11.4 Intrinsic Imaging Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.11.5 Intrinsic Imaging Recent Development
11.12 Median Technologies
11.12.1 Median Technologies Company Details
11.12.2 Median Technologies Business Overview
11.12.3 Median Technologies Clinical Trial Imaging Service Introduction
11.12.4 Median Technologies Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.12.5 Median Technologies Recent Development
11.13 Cardiovascular Imaging Technologies
11.13.1 Cardiovascular Imaging Technologies Company Details
11.13.2 Cardiovascular Imaging Technologies Business Overview
11.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Service Introduction
11.13.4 Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.13.5 Cardiovascular Imaging Technologies Recent Development
11.14 Banook Medical
11.14.1 Banook Medical Company Details
11.14.2 Banook Medical Business Overview
11.14.3 Banook Medical Clinical Trial Imaging Service Introduction
11.14.4 Banook Medical Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.14.5 Banook Medical Recent Development
11.15 IXICO
11.15.1 IXICO Company Details
11.15.2 IXICO Business Overview
11.15.3 IXICO Clinical Trial Imaging Service Introduction
11.15.4 IXICO Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.15.5 IXICO Recent Development
11.16 Keosys
11.16.1 Keosys Company Details
11.16.2 Keosys Business Overview
11.16.3 Keosys Clinical Trial Imaging Service Introduction
11.16.4 Keosys Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.16.5 Keosys Recent Development
11.17 Konica Minolta
11.17.1 Konica Minolta Company Details
11.17.2 Konica Minolta Business Overview
11.17.3 Konica Minolta Clinical Trial Imaging Service Introduction
11.17.4 Konica Minolta Revenue in Clinical Trial Imaging Service Business (2020-2025)
11.17.5 Konica Minolta Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Trial Imaging Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In-house Imaging Service
Table 3. Key Players of Central Imaging Service
Table 4. Global Clinical Trial Imaging Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Clinical Trial Imaging Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Trial Imaging Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Clinical Trial Imaging Service Market Share by Region (2020-2025)
Table 8. Global Clinical Trial Imaging Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Clinical Trial Imaging Service Market Share by Region (2026-2031)
Table 10. Clinical Trial Imaging Service Market Trends
Table 11. Clinical Trial Imaging Service Market Drivers
Table 12. Clinical Trial Imaging Service Market Challenges
Table 13. Clinical Trial Imaging Service Market Restraints
Table 14. Global Clinical Trial Imaging Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Clinical Trial Imaging Service Market Share by Players (2020-2025)
Table 16. Global Top Clinical Trial Imaging Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging Service as of 2024)
Table 17. Ranking of Global Top Clinical Trial Imaging Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Clinical Trial Imaging Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Clinical Trial Imaging Service, Headquarters and Area Served
Table 20. Global Key Players of Clinical Trial Imaging Service, Product and Application
Table 21. Global Key Players of Clinical Trial Imaging Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clinical Trial Imaging Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Clinical Trial Imaging Service Revenue Market Share by Type (2020-2025)
Table 25. Global Clinical Trial Imaging Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Clinical Trial Imaging Service Revenue Market Share by Type (2026-2031)
Table 27. Global Clinical Trial Imaging Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Clinical Trial Imaging Service Revenue Market Share by Application (2020-2025)
Table 29. Global Clinical Trial Imaging Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Clinical Trial Imaging Service Revenue Market Share by Application (2026-2031)
Table 31. North America Clinical Trial Imaging Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Clinical Trial Imaging Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Clinical Trial Imaging Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Clinical Trial Imaging Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Clinical Trial Imaging Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Clinical Trial Imaging Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Clinical Trial Imaging Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Clinical Trial Imaging Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Clinical Trial Imaging Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Clinical Trial Imaging Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Clinical Trial Imaging Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Clinical Trial Imaging Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Clinical Trial Imaging Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. ICON Company Details
Table 47. ICON Business Overview
Table 48. ICON Clinical Trial Imaging Service Product
Table 49. ICON Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 50. ICON Recent Development
Table 51. ERT Company Details
Table 52. ERT Business Overview
Table 53. ERT Clinical Trial Imaging Service Product
Table 54. ERT Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 55. ERT Recent Development
Table 56. McLaren Company Details
Table 57. McLaren Business Overview
Table 58. McLaren Clinical Trial Imaging Service Product
Table 59. McLaren Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 60. McLaren Recent Development
Table 61. Bioclinica Company Details
Table 62. Bioclinica Business Overview
Table 63. Bioclinica Clinical Trial Imaging Service Product
Table 64. Bioclinica Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 65. Bioclinica Recent Development
Table 66. Parexel Company Details
Table 67. Parexel Business Overview
Table 68. Parexel Clinical Trial Imaging Service Product
Table 69. Parexel Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 70. Parexel Recent Development
Table 71. BioTelemetry Company Details
Table 72. BioTelemetry Business Overview
Table 73. BioTelemetry Clinical Trial Imaging Service Product
Table 74. BioTelemetry Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 75. BioTelemetry Recent Development
Table 76. ProScan Imaging Company Details
Table 77. ProScan Imaging Business Overview
Table 78. ProScan Imaging Clinical Trial Imaging Service Product
Table 79. ProScan Imaging Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 80. ProScan Imaging Recent Development
Table 81. Imaging Endpoints Company Details
Table 82. Imaging Endpoints Business Overview
Table 83. Imaging Endpoints Clinical Trial Imaging Service Product
Table 84. Imaging Endpoints Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 85. Imaging Endpoints Recent Development
Table 86. Radiant Sage Company Details
Table 87. Radiant Sage Business Overview
Table 88. Radiant Sage Clinical Trial Imaging Service Product
Table 89. Radiant Sage Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 90. Radiant Sage Recent Development
Table 91. Micron, Inc. Company Details
Table 92. Micron, Inc. Business Overview
Table 93. Micron, Inc. Clinical Trial Imaging Service Product
Table 94. Micron, Inc. Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 95. Micron, Inc. Recent Development
Table 96. Intrinsic Imaging Company Details
Table 97. Intrinsic Imaging Business Overview
Table 98. Intrinsic Imaging Clinical Trial Imaging Service Product
Table 99. Intrinsic Imaging Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 100. Intrinsic Imaging Recent Development
Table 101. Median Technologies Company Details
Table 102. Median Technologies Business Overview
Table 103. Median Technologies Clinical Trial Imaging Service Product
Table 104. Median Technologies Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 105. Median Technologies Recent Development
Table 106. Cardiovascular Imaging Technologies Company Details
Table 107. Cardiovascular Imaging Technologies Business Overview
Table 108. Cardiovascular Imaging Technologies Clinical Trial Imaging Service Product
Table 109. Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 110. Cardiovascular Imaging Technologies Recent Development
Table 111. Banook Medical Company Details
Table 112. Banook Medical Business Overview
Table 113. Banook Medical Clinical Trial Imaging Service Product
Table 114. Banook Medical Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 115. Banook Medical Recent Development
Table 116. IXICO Company Details
Table 117. IXICO Business Overview
Table 118. IXICO Clinical Trial Imaging Service Product
Table 119. IXICO Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 120. IXICO Recent Development
Table 121. Keosys Company Details
Table 122. Keosys Business Overview
Table 123. Keosys Clinical Trial Imaging Service Product
Table 124. Keosys Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 125. Keosys Recent Development
Table 126. Konica Minolta Company Details
Table 127. Konica Minolta Business Overview
Table 128. Konica Minolta Clinical Trial Imaging Service Product
Table 129. Konica Minolta Revenue in Clinical Trial Imaging Service Business (2020-2025) & (US$ Million)
Table 130. Konica Minolta Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Clinical Trial Imaging Service Picture
Figure 2. Global Clinical Trial Imaging Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Trial Imaging Service Market Share by Type: 2024 VS 2031
Figure 4. In-house Imaging Service Features
Figure 5. Central Imaging Service Features
Figure 6. Global Clinical Trial Imaging Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Clinical Trial Imaging Service Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Medical Device Manufacturers Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Clinical Trial Imaging Service Report Years Considered
Figure 14. Global Clinical Trial Imaging Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Clinical Trial Imaging Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Clinical Trial Imaging Service Market Share by Region: 2024 VS 2031
Figure 17. Global Clinical Trial Imaging Service Market Share by Players in 2024
Figure 18. Global Clinical Trial Imaging Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Clinical Trial Imaging Service Revenue in 2024
Figure 20. North America Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Clinical Trial Imaging Service Market Share by Country (2020-2031)
Figure 22. United States Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Clinical Trial Imaging Service Market Share by Country (2020-2031)
Figure 26. Germany Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Clinical Trial Imaging Service Market Share by Region (2020-2031)
Figure 34. China Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Clinical Trial Imaging Service Market Share by Country (2020-2031)
Figure 42. Mexico Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Clinical Trial Imaging Service Market Share by Country (2020-2031)
Figure 46. Israel Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Clinical Trial Imaging Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. ICON Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 50. ERT Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 51. McLaren Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 52. Bioclinica Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 53. Parexel Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 54. BioTelemetry Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 55. ProScan Imaging Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 56. Imaging Endpoints Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 57. Radiant Sage Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 58. Micron, Inc. Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 59. Intrinsic Imaging Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 60. Median Technologies Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 61. Cardiovascular Imaging Technologies Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 62. Banook Medical Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 63. IXICO Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 64. Keosys Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 65. Konica Minolta Revenue Growth Rate in Clinical Trial Imaging Service Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
